John Stanford
speaker
1,479 appearances
11 recordings
1 series
first heard May 2026
last heard 13 Aug
John Stanford’s voice in public audio — every appearance, attributed to the second.
Trend
recordings per month · last 12 monthsRecordings per month over the last 12 months — 11 in all, peaking in Jul 2026 with 4.
Appearances
At Making Medicine, we're reporting on the headlines, not making medical recommendations.
voice-verified
For personal health questions, always ask your doctor.
voice-verified
Nothing in this episode constitutes investment, financial, or legal advice.
voice-verified
Consult your own advisors before making decisions.
voice-verified
Welcome back to the Making Medicine Podcast, where science, policy, and innovation meet.
voice-verified
I'm your host, John Stanford.
voice-verified
On this episode of our How America Makes Medicine series, we're talking with Jeremy Levin, a universally known figure that has sat on all sides of the pharmaceutical innovation we've been talking about.
voice-verified
Dr.
voice-verified
Levin led global business development at Novartis before architecting BMS's string of pearls strategy, which was a major inflection point in how large manufacturers do RD.
voice-verified
He then served as president and CEO of TEVA and is now executive chairman of Ovid Therapeutics and Chairman Emeritus of Bio, the trade association that has done a lot engaging around policy and advocacy.
voice-verified
It's a remarkable, almost unmatched career.
voice-verified
And these days, Dr.
voice-verified
Levin is also carving out a growing thought leadership role on how America stays competitive.
voice-verified
He did that most recently as the author of his new book, Biotech in the Balance: Saving a Strategic Industry in an Age of Distrust.
voice-verified
He's the perfect guest as our series transitions into how medicines get to patients, and he even shares insights on the hottest topics of today.
voice-verified
So let's get into the show.
voice-verified
Throughout our How America Makes Medicine series, we're taking brief moments in every episode to do a little history, but this one's particularly special.
voice-verified
As we left off last episode, the biotech revolution had begun.
voice-verified
Ecosystem was developing for early stage companies to develop, the NIH, the FDA, it was all moving in the right direction.
voice-verified
But up until the early 2000s, the big news in acquisitions and mergers were large companies buying each other.
voice-verified
Showing 1–20 of 1,479 · page 1 of 74
Next →